SCHEMBL23297612

SCHEMBL23297612

Cn1c(=O)c2c(nc(Cl)n2Cc2csc(-c3ccc(Cl)cc3)n2)n(C)c1=O

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 4/20 0.66
▸ ADORA2A P29274 3/20 0.66
▸ ADORA1 P30542 3/20 0.66
▸ HTT P42858 3/20 0.58
▸ CYP1A2 P05177 2/20 0.55
▸ CYP2C19 P33261 2/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ TSHR P16473 2/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ ADORA3 P0DMS8 1/20 0.51
▸ ALDH1A1 P00352 3/20 0.50
▸ NPSR1 Q6W5P4 3/20 0.50
▸ MAPT P10636 3/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ LMNA P02545 1/20 0.49
▸ ATM Q13315 1/20 0.48
▸ RECQL P46063 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23297620 0.93 HTT (0.57) MAOBADORA2AADORA1HTTCYP1A2
SCHEMBL23297637 0.92 HTT (0.56) MAOBADORA2AADORA1HTTCYP1A2
SCHEMBL23297598 0.92 HTT (0.56) MAOBADORA2AADORA1HTTCYP1A2
SCHEMBL23297564 0.92 HTT (0.58) MAOBADORA2AADORA1HTTCYP1A2
SCHEMBL23297748 0.91 HTT (0.55) MAOBADORA2AADORA1HTTCYP1A2
SCHEMBL23297609 0.90 ADORA2A (0.54) MAOBADORA2AADORA1HTTCYP1A2
SCHEMBL20680543 0.88 ADORA2A (0.53) MAOBADORA2AADORA1HTTCYP1A2
SCHEMBL23297759 0.88 HTT (0.54) MAOBADORA2AADORA1HTTCYP1A2
SCHEMBL23297630 0.86 ADORA2A (0.54) MAOBADORA2AADORA1HTTCYP1A2
SCHEMBL23297562 0.86 HTT (0.52) MAOBADORA2AADORA1HTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210128566-A1 NOVEL FUNCTIONALIZED PURINE-2,6-DIONES AND THEIR USE IN MEDICINE THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING (SE) 2021-05-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210128566-A1 NOVEL FUNCTIONALIZED PURINE-2,6-DIONES AND THEIR USE IN MEDICINE ADORA2A, HPRT1, PNP MAOB 970/4885ADORA2A 1/4885ADORA1 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback